# Supportive Versus Immunosuppressive Therapy for the Treatment Of Progressive IgA Nephropathy

> **NCT00554502** · PHASE3 · COMPLETED · sponsor: **RWTH Aachen University** · enrollment: 148 (estimated)

## Conditions studied

- IgA Nephropathy

## Interventions

- **DRUG:** supportive therapy with: ACE-inhibitor / ARB / Statin
- **DRUG:** supportive and immunosuppressive therapy

## Key facts

- **NCT ID:** NCT00554502
- **Lead sponsor:** RWTH Aachen University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2015-02
- **Final completion:** 2015-02
- **Target enrollment:** 148 (ESTIMATED)
- **Last updated:** 2015-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00554502

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00554502, "Supportive Versus Immunosuppressive Therapy for the Treatment Of Progressive IgA Nephropathy". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00554502. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*